Navigation Links
When you cough up green or yellow phlegm you need to be prescribed antibiotics, right?
Date:3/24/2011

Prescribing antibiotics for patients with discoloured phlegm caused by acute cough has little or no effect on alleviating symptoms and recovery, a Cardiff University study has found.

Acute cough is one of the common reasons why people visit their GP and accounts for a large proportion of antibiotics prescribed in the community. One of the most common questions asked by GPs to their patients is about their phlegm: "Are you coughing anything up?" or "What colour is your phlegm?"

Clinicians and patients commonly believe that yellow and green phlegm production is associated with a bacterial infection, which is more likely to benefit from antibiotic treatment compared to non-productive cough or cough that produces clear phlegm.

However, in a new study published in the European Respiratory Journal, Professor Chris Butler and his team from Cardiff University's School of Medicine, together with colleagues from 14 European centres present data from an observational study of 3402 adult patients with acute cough presenting for health care in 14 primary care networks.

The research found that patients producing discoloured phlegm are prescribed antibiotics more frequently than those not producing phlegm unlike those producing clear/white phlegm.

Crucially, antibiotic treatment was not associated with greater rate or magnitude of symptoms score resolution among those who produced yellow or green phlegm. Neither was recovery among those feeling generally unwell on its own, or taken together with phlegm production, associated with antibiotic treatment.

Clinicians and patients are therefore likely to both be over interpreting the importance of the colour of phlegm in the decision whether or not to prescribe, or take, antibiotics.

Professor Butler, who led the study said: "One of the exciting things about this research is that our findings from this large, multi-country observational study resonate with
'/>"/>

Contact: Angela Watkins
WatkinsA6@cardiff.ac.uk
44-029-208-7190
Cardiff University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds
2. Parents Still Giving Cough, Cold Meds to Kids Under 2: Poll
3. Cough Syrup Might Help With Dosing of Breast Cancer Drug
4. Cough medicine could help doctors identify how breast cancer patients metabolize tamoxifen
5. Too Few Adults Vaccinated Against Whooping Cough: CDC
6. Spread of Whooping Cough Raises Concern
7. Commentary suggests alternatives to routine use of OTC cold/cough meds in children
8. New commentary suggests alternatives to routine use of OTC cold/cough meds in children
9. TechWorld Medicals NasalCare Nasal Cleanse Kit Named “Best New Product” at ECRM Cough & Cold and Allergy Conference
10. Conference highlights UC Berkeleys unique approach to green chemistry
11. Going Green May Cut Hospital Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th consecutive session ... Compass® has taken place at Kingsborough Community College in Brooklyn in each of the ... for Calvary, and two junior counselors who were campers themselves just a few years ...
(Date:9/1/2015)... Jersey (PRWEB) , ... September 01, 2015 , ... Horizon ... of the 50 Best Companies for Latinas in the LATINA Style 50 Report that ... States. , For 2015, Horizon BCBSNJ climbs from number 24 to ...
(Date:9/1/2015)... London, UK (PRWEB) , ... ... ... are constantly seeking better therapeutic options to efficiently cure and prevent different ... classes. Different cancers have different pathophysiological properties due to which distinctive approach ...
(Date:9/1/2015)... ... September 01, 2015 , ... As part of its ... Shield of Minnesota (Blue Cross) has announced Doctor On Demand as the company’s ... Doctor On Demand provides immediate access to Board Certified physicians or next-day appointments ...
(Date:9/1/2015)... UK (PRWEB) , ... September 01, 2015 , ... ... a vacuum that creates negative pressure inside a wound to remove exudates, fluid, ... for treatment devices (comprising portable devices, stand-alone devices, disposable devices, and canisters, etc.) ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3
... seemed to suggest that supplementing the diet with vitamin ... a study published In Journal Of American Medical association, ... be something very different. ,The researchers had ... Evaluation or HOPE centers between 1993 and 1999, and ...
... the fishes contains a property that may cure inflammatory conditions ... in a diet supplemented by low doses of aspirin is ... case of absence of fish, a supplement of fish oil ... shown previously that omega-3 fatty acids in conjunction with daily ...
... that lowering LDL cholesterol (“bad” cholesterol) to below ... a // cholesterol-lowering drug is safe and results in ... disease patients. They initially took 10 milligrams of atorvastatin ... to 130 milligrams per deciliter a day or lower. ...
... have been conducted to see whether antihypertensive strategies ... // are superior to older treatments with beta-blockers ... calcium channel blocker amlodipine with or without the ... or without the diuretic bendroflumethiazide. ,The trial ...
... stem cell research that will help in numerous therapies using ... growing human embryonic stem cells in the laboratory. ... important role in regeneration of cells for therapeutic use. However, ... live animal cells and serum and run the risk of ...
... issue of Journal of American Medical Association, researchers have pointed ... delaying the vaccination schedules of the children resulting in increase ... ,According to the latest study, most of the vaccines ... of age in children often gets delayed due to a ...
Cached Medicine News:
(Date:9/1/2015)... 2015  Amgen (NASDAQ: AMGN ) today ... areas of Alzheimer,s disease and migraine. The collaboration ... teaming up with Novartis on a differentiated and ... predisposed individuals at risk of developing Alzheimer,s disease. ... commercialization of its migraine programs in the U.S., ...
(Date:9/1/2015)... , Sept. 1, 2015 Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... its preliminary response to the Patent Trial and Appeals ... inter partes review (IPR), filed by a unit of ... in U.S. Patent No. 8,359,102 (the ,102 patent). The ,102 ...
(Date:9/1/2015)... THOUSAND OAKS, Calif. and ... (NASDAQ: AMGN ) and UCB (Euronext Brussels: ... trial (STudy evaluating effect of RomosozUmab Compared with ... risk for fracture pReviously treated with bisphosphonatE therapy). ... a statistically significant difference in favor of romosozumab ...
Breaking Medicine Technology:Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... N.Y., Jan. 20, 2011 Whenever someone needs high-quality drugs ... place their order. However, because of the large choice of ... decision. Rx-webmasters.com was launched to make things simpler and safer ... purchase any other drugs. The website promotion is the responsibility ...
... Jan. 19, 2011 Boston Scientific Corporation (NYSE: ... subsidiary, Boston Scientific Japan K.K., has reached an ... and sell its cardiac rhythm management (CRM) devices ... resources, distribution network and service capabilities will complement ...
Cached Medicine Technology:New Online Pharmacy Rx-webmasters.com Allows Customers to Pay Less for High-Quality Drugs 2Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan 2Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan 3
... Needles are preominantly used for routine blood ... colour of the needle protective cap simplifies ... For example, yellow symbolises the needle dimension ... (0.80 mm) and black 22 G (0.70 ...
DiaMed-ID Micro Typing System...
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... cell runs up to 12 mini gels ... Handcast gels can be poured 12 at ... gradient former and Mini-PROTEAN 3 multi-casting chamber, ... Alternatively, Ready Gel precast gels offer the ...
Medicine Products: